Lum R T, Nelson M G, Joly A, Horsma A G, Lee G, Meyer S M, Wick M M, Schow S R
CV Therapeutics Inc. Palo Alto, CA 94304, USA.
Bioorg Med Chem Lett. 1998 Feb 3;8(3):209-14. doi: 10.1016/s0960-894x(98)00015-8.
Potent inhibitors of the 20S proteasome that contain a novel indanone head group coupled to di and tripeptides are described. These compounds are the first proteasome inhibitors have demonstrated high selectivity for the chymotrypsin-like activity of the 20S proteasome.